SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease

@inproceedings{Shehadeh2010SRRM2AP,
  title={SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease},
  author={Lina A. Shehadeh and Kristine Yu and Liyong Wang and Alexandra Guevara and Carlos Singer and Jeffery M. Vance and Spyridon Papapetropoulos},
  booktitle={PloS one},
  year={2010}
}
  • Lina A. Shehadeh, Kristine Yu, +4 authors Spyridon Papapetropoulos
  • Published in PloS one 2010
  • Biology, Medicine
  • BACKGROUND Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects about five million people worldwide. Diagnosis remains clinical, based on phenotypic patterns. The discovery of laboratory markers that will enhance diagnostic accuracy, allow pre-clinical detection and tracking of disease progression is critically needed. These biomarkers may include transcripts with different isoforms. METHODOLOGY/PRINCIPAL FINDINGS We performed extensive analysis on 3 PD microarray… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 49 CITATIONS

    Parkinson's disease: molecular risk factors.

    VIEW 13 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson’s patients leukocytes

    VIEW 4 EXCERPTS
    CITES METHODS & BACKGROUND
    HIGHLY INFLUENCED

    Expression and Regulation of the Endogenous Retrovirus 3 in Hodgkin’s Lymphoma Cells

    VIEW 3 EXCERPTS
    CITES BACKGROUND & METHODS
    HIGHLY INFLUENCED

    Alternative splicing isoforms in health and disease

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 38 REFERENCES

    Molecular markers of early Parkinson's disease based on gene expression in blood.

    VIEW 17 EXCERPTS